EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC 4.0

Plasma metabolomic profiles associated with breastfeeding history and subsequent ovarian cancer risk

Plasmatische metabolomische Profile in Zusammenhang mit Stillgeschichte und anschließendem Ovarialkarzinomrisiko

Jennifer M Mongiovi iD, Nicole Prince, Julian Avila Pacheco, Nan Lin iD, Mary K Townsend, Britton Trabert iD, Nicolas Wentzensen iD, Jessica A Lasky-Su, A Heather Eliassen iD, Clary B Clish, Shelley S Tworoger iD, Oana A Zeleznik und 1 weitere

JNCI Cancer Spectrum · 02.11.2026 · 10 (6)

DOI: 10.1093/jncics/pkag108 ↗

Auf einen Blick

Ein metabolitbasierter Still-Score war mit einem geringeren Ovarialkarzinomrisiko verbunden. Besonders PC- und PE-Stoffwechselwege zeigten Zusammenhänge mit längerem Stillen.

Fragestellung

Ist ein zuvor berichteter metabolitbasierter Still-Score mit dem Risiko für epitheliales Ovarialkarzinom assoziiert?

Methode

Fall-Kontroll-Studien in NHS/NHSII und PLCO mit logistischer Regression und Metaanalyse; zusätzlich Analyse von 606 Still-Metabolit-Assoziationen in NHS/NHSII und VDAART.

Ergebnisse

Die höchste Quartile des metabolitbasierten Still-Scores war invers mit dem Ovarialkarzinomrisiko assoziiert: gepooltes OR 0,62 (95 %-KI 0,39–0,99). 11 von 14 Metaboliten zeigten in VDAART dieselbe Richtung.

Schlussfolgerung der Autor:innen

Die Ergebnisse sprechen dafür, dass Veränderungen des systemischen Metabolismus, besonders in PC- und PE-Pfaden, Einblick in biologische Wege des inversen Zusammenhangs zwischen Stillen und Ovarialkarzinom geben.

Kernaussagen

  • Höchste Quartile des Still-Scores: OR 0,62 (95 %-KI 0,39–0,99)
  • PCs (NES 1,94; FDR 0,004) und PEs (NES 1,82; FDR 0,01) waren mit Stilldauer verknüpft
  • 10 Metaboliten waren positiv mit Stillen und invers mit Ovarialkarzinom assoziiert

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Metaanalyse in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 10.10.2026. Verfasst von Jennifer M Mongiovi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, United States. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Breast Feeding, Neoplasms, Glandular and Epithelial. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, American Cancer Society Research Scholar Grant, NHS.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breastfeeding reduces ovarian cancer risk, but the underlying biological mechanisms remain unclear.

Methods

We examined the association between a previously reported metabolite-based breastfeeding score with incident epithelial ovarian cancer risk in case-control studies nested within the Nurses’ Health Studies (NHS/NHSII, n = 436) and Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO, n = 300) using conditional logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for each study and conducted a meta-analysis. We investigated 606 individual breastfeeding-metabolite associations among 9904 midlife parous women in NHS/NHSII and 663 1-year postpartum women in the Vitamin D Antenatal Asthma Reduction Trial (VDAART). Metabolites associated with breastfeeding at P ≤ .05 after multiple testing correction for number of effective tests (NEF) were then assessed for their associations with ovarian cancer. Metabolite set enrichment analysis using Normalized Enrichment Score (NES)-identified metabolite classes associated with breastfeeding using false discovery rate (FDR) for multiple testing correction.

Results

The highest quartile of metabolite-based breastfeeding score was inversely associated with ovarian cancer risk (meta-analyzed odds ratio [OR] = 0.62, 95% CI = 0.39 to 0.99). Of the 14 individual metabolites associated with breastfeeding in NHS/NHSII and also measured in VDAART, similar direction of associations was observed for 11 metabolites. Phosphatidylcholines (PCs; NES = 1.94; FDR = 0.004) and phosphatidylethanolamines (PEs; NES = 1.82; FDR = 0.01) were positively enriched with increased breastfeeding duration. Ten metabolites including PCs and PEs were positively associated with breastfeeding and inversely associated with ovarian cancer.

Conclusion

Our results suggest alterations of systemic metabolism, particularly among PC and PE pathways, provide insight into biological pathways underlying the inverse breastfeeding-ovarian cancer association.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsBreast FeedingNeoplasms, Glandular and EpithelialHumansFemaleCase-Control StudiesAdultMiddle AgedOdds RatioRisk FactorsLogistic ModelsPhosphatidylethanolaminesPhosphatidylcholinesCarcinoma, Ovarian EpithelialMetabolomics

Substanzen

PhosphatidylethanolaminesPhosphatidylcholinesphosphatidylethanolamine

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, United States.
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
  • Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
  • Metabolomics Platform, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, United States.
  • Division of Oncological Sciences, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States.
  • Cancer Control and Population Sciences, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, United States.

ORCID-Profile: Jennifer M Mongiovi, Nan Lin, Britton Trabert, Nicolas Wentzensen, A Heather Eliassen, Shelley S Tworoger

Förderung

  • NCI NIH HHS
  • American Cancer Society Research Scholar Grant
  • NHS

Zitieren

APA

Mongiovi, J. M., Prince, N., Pacheco, J. A., Lin, N., Townsend, M. K., Trabert, B., Wentzensen, N., Lasky-Su, J. A., Eliassen, A. H., Clish, C. B., Tworoger, S. S., Zeleznik, O. A., & Sasamoto, N. (2026). Plasma metabolomic profiles associated with breastfeeding history and subsequent ovarian cancer risk. JNCI Cancer Spectrum, 10(6). https://doi.org/10.1093/jncics/pkag108

Vancouver

Mongiovi JM, Prince N, Pacheco JA, Lin N, Townsend MK, Trabert B, et al. Plasma metabolomic profiles associated with breastfeeding history and subsequent ovarian cancer risk. JNCI Cancer Spectrum. 2026;10(6). doi:10.1093/jncics/pkag108

BibTeX
@article{Mongiovi2026,
  author = {Mongiovi, Jennifer M and Prince, Nicole and Pacheco, Julian Avila and Lin, Nan and Townsend, Mary K and Trabert, Britton and Wentzensen, Nicolas and Lasky-Su, Jessica A and Eliassen, A Heather and Clish, Clary B and Tworoger, Shelley S and Zeleznik, Oana A and Sasamoto, Naoko},
  title = {Plasma metabolomic profiles associated with breastfeeding history and subsequent ovarian cancer risk},
  journal = {JNCI Cancer Spectrum},
  year = {2026},
  volume = {10},
  number = {6},
  doi = {10.1093/jncics/pkag108}
}
Kostenlos starten →